132 related articles for article (PubMed ID: 11531139)
21. Morphometry of bladder carcinoma: definition of a new variable.
Sowter C; Sowter G; Slavin G; Rosen D
Anal Cell Pathol; 1990 Jul; 2(4):205-13. PubMed ID: 2275868
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables].
Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M
Hinyokika Kiyo; 1992 Dec; 38(12):1361-8. PubMed ID: 1288224
[TBL] [Abstract][Full Text] [Related]
24. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma.
Su JS; Arima K; Hasegawa M; Franco OE; Yanagawa M; Sugimura Y; Kawamura J
Hinyokika Kiyo; 2003 Nov; 49(11):649-58. PubMed ID: 14719452
[TBL] [Abstract][Full Text] [Related]
25. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
Kuczyk MA; Serth J; Bokemeyer C; Hervatin C; Oelke M; Oelert F; Höfner K; Jonas U
Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
27. Cell kinetics analysis in stage I endometrial carcinoma as determined by image cytometry and immunohistochemistry. Correlation with clinicopathologic characteristics.
Miliaras D; Papaemmanuil S
Anal Quant Cytol Histol; 2004 Feb; 26(1):7-14. PubMed ID: 15032075
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
29. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.
Pfister C; Lacombe L; Vezina MC; Moore L; Larue H; Têtu B; Meyer F; Fradet Y
Hum Pathol; 1999 Nov; 30(11):1350-5. PubMed ID: 10571516
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
33. [Morphometric study of transitional carcinoma of the bladder (I): analysis of 148 superficial tumors].
Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Goméz MA; Fernández Gómez JM; Concepción Masip T
Arch Esp Urol; 1991 Apr; 44(3):243-9. PubMed ID: 1867504
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of the stereological estimation of mean nuclear volume in human bladder carcinoma--relation to tumor grade, stage and prognosis].
Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M; Yamabe H
Hinyokika Kiyo; 1992 Jan; 38(1):25-9. PubMed ID: 1546565
[TBL] [Abstract][Full Text] [Related]
35. p53 Gene mutations in superficial bladder cancer.
Lorenzo Romero JG; Salinas Sánchez AS; Giménez Bachs JM; Sánchez Sánchez F; Escribano Martínez J; Hernández Millán IR; Segura Martín M; Virseda Rodríguez JA
Urol Int; 2004; 73(3):212-8. PubMed ID: 15539839
[TBL] [Abstract][Full Text] [Related]
36. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
37. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
Lipponen P; Eskelinen M
Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
[TBL] [Abstract][Full Text] [Related]
38. The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma.
Borland RN; Partin AW; Epstein JI; Brendler CB
J Urol; 1993 Feb; 149(2):272-5. PubMed ID: 8426399
[TBL] [Abstract][Full Text] [Related]
39. Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions.
Stavropoulos NE; Ioackim-Velogianni E; Hastazeris K; Kitsiou E; Stefanaki S; Agnantis N
Br J Urol; 1993 Nov; 72(5 Pt 2):736-9. PubMed ID: 8281405
[TBL] [Abstract][Full Text] [Related]
40. [A morphometric grading study on the nucleus shape and DNA-content of transitional cell carcinoma of urinary bladder].
Xia TL
Zhonghua Bing Li Xue Za Zhi; 1992 Aug; 21(4):202-5. PubMed ID: 1473202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
